Reuters logo
BRIEF-IRLAB Therapeutics July-Sept operating loss widens to SEK 20.7 mln
November 15, 2017 / 7:02 AM / 4 days ago

BRIEF-IRLAB Therapeutics July-Sept operating loss widens to SEK 20.7 mln

Nov 15 (Reuters) - IRLAB THERAPEUTICS AB:

* JUL-SEPT NET SALES SEK 46,000 VERSUS SEK 96,000 YEAR AGO‍​

* JUL-SEPT OPERATING LOSS SEK 20.7 MILLION VERSUS LOSS 10.6 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below